Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study이탈리아에서 델타 변이체의 우세한 순환 동안 mRNA 백신의 효과 및 SARS-CoV-2 감염 및 중증 covid-19에 대한 보호 약화: 후향적 코호트 연구Article Published on 2022-02-102022-09-11 Journal: The BMJ [Category] COVID19(2023년), SARS, 변종, [키워드] 95% confidence interval Admission age BNT162b2 booster dose brand calculated circulation cohort study covariates death delta variant diagnosis of SARS-CoV-2 Effectiveness eligible first dose General population Geographic healthcare worker Healthcare workers high risk hospital incidence Infection Italy Moderna mRNA mRNA vaccine mRNA vaccines mRNA-1273 of BNT162b2 offer outcome Pfizer-BioNTech predominant previous diagnosis random effect rate ratio receive retrospective cohort study risk Risk category robust SARS-COV-2 infection SARS-CoV-2 virus second dose second dose of vaccine severe COVID-19 significantly Support the epidemic the SARS-CoV-2 virus time interval time intervals vaccination Vaccine variant [DOI] 10.1136/bmj-2021-069052 PMC 바로가기 [Article Type] Article
Insight into the Advances in Clinical Trials of SARS-CoV-2 VaccinesReview Article Published on 2022-02-092022-10-31 Journal: The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale [Category] COVID-19, [키워드] acute respiratory syndrome administration advance approved ChAdOx1 clinical clinical trial complications contagious CoronaVac Coronavirus-2 COVID-19 vaccine effective Efficacy Emergency use authorization evaluate Gam-COVID-Vac healthcare Immunity Infection insight Intervention janssen limit mixture Moderna mRNA mutant strain neutralizing antibody Occurrence pandemic peptide Prevent proportion reported robust SARS-CoV-2 Scientific community shown Spread tested the SARS-CoV-2 Vaccinating vaccination Vaccine Vaccines variants virus [DOI] 10.1155/2022/6913772 PMC 바로가기 [Article Type] Review Article
COVID-19 Vaccine Tweets After Vaccine Rollout: Sentiment–Based Topic ModelingOriginal Paper Published on 2022-02-082022-10-30 Journal: Journal of Medical Internet Research [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] applied AstraZeneca automated calculated categories changed collected Community COVID-19 COVID-19 vaccine COVID-19 vaccines demonstrated determine distribution effective effort evaluate Evolution extreme heatmap help information Johnson & Johnson knowledge media modeling Moderna Neutral objective pandemic Pfizer positive programming promote Research Result sentiment evolution Side effect social media study period text mining the vaccine Topic topic modeling vaccinate vaccination Vaccine Vaccine hesitancy widespread [DOI] 10.2196/31726 PMC 바로가기 [Article Type] Original Paper
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concernmRNA-1273 백신 유도 항체는 우려되는 SARS-CoV-2 변이체 전반에 걸쳐 Fc 효과기 기능을 유지합니다Article Published on 2022-02-082022-09-11 Journal: Immunity [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] antibody approved binding both groups contribute convalescent convalescent individuals COVID-19 COVID-19 vaccine Efficacy exhibited Fc effector function function functional functional capacity functions humoral immune response in both groups independent independent of Interaction maintain Moderna mRNA mRNA vaccine mRNA-1273 mRNA-1273 vaccination neutralization Neutralizing neutralizing response neutralizing responses offer Protective Resilience response robust SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 variant SARS-CoV-2 variants the disease These data vaccine-induced antibodies vaccine-induced antibody Vaccines variant variants variants of concern VoC VOCs [DOI] 10.1016/j.immuni.2022.01.001 PMC 바로가기 [Article Type] Article
Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune responseSARS-CoV-2 mRNA 백신 접종 후 88세 남성의 3차 뇌신경 마비: 주사 부위 및 백신 유형의 변경으로 인해 체액성 면역 반응과 함께 사건이 없는 2차 접종Case Reports Published on 2022-02-082022-09-12 Journal: BMJ case reports [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] administration adverse effect AEs Antibody Response Awareness COVID-19 cranial cranial nerves dose Effect effective European Evidence humoral immune response hypothesised imaging immune protection IMPROVE injection management Medicine Moderna mRNA mRNA-1273 oral steroid patients peripheral nerve disease Pfizer robust Safe SARS-CoV-2 SARS-CoV-2 vaccine second dose selected the patient Unwanted effects / adverse reactions Vaccination/immunisation Vaccine Vascular [DOI] 10.1136/bcr-2021-246485 PMC 바로가기 [Article Type] Case Reports
Lymphadenopathy post‐COVID‐19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic reviewReview Published on 2022-02-072022-10-04 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 치료기술, [키워드] approved AstraZeneca AztraZeneca biopsies biopsy caused changes in coronavirus Coronavirus disease 2019 COVID‐19 COVID‐19 COVID‐19 vacccine database death drug Efficacy and safety FDG fluorodeoxyglucose (FDG) PET‐CT scan food global pandemic help identify incidence injection ipsilateral janssen knowledge Lymph node Lymphadenopathy malignancies management Metastasis Moderna oncologist pathologic Patient patients Pfizer presenting Prevent radiologist reactive reported risk shown Side effect systematic literature search systematic review the vaccine tomography Transmission vaccination Vaccine was performed [DOI] 10.1002/jmv.27599 PMC 바로가기 [Article Type] Review
Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario Research Published on 2022-02-072022-10-05 Journal: Nature Microbiology [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] AstraZeneca B.1.1.7 B.1.351 B.1.617.2 benefit Beta Canada caused ChAdOx1 combinations COVID-19 hospitalization COVID-19 vaccine death Delta disease severity dose Effectiveness estimate Gamma greater Hospitalization individual Moderna mRNA-1273 of BNT162b2 Older outcome P.1 Pfizer-BioNTech receiving SARS-CoV-2 SARS-CoV-2 variant second dose symptomatic symptomatic infection symptomatic SARS-CoV-2 infection tested Vaccine variants of concern VoC [DOI] 10.1038/s41564-021-01053-0 [Article Type] Research
Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United StatesPublic Health Published on 2022-02-032022-10-31 Journal: Frontiers in Public Health [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] Adverse Adverse reaction age allergic Allergic reactions analysed arrhythmia AstraZeneca calculated Cardiovascular events categories category chimeric virus vaccines Coagulation common COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines death drug estimate European Frequency higher risk hospitalisations individual Influenza influenza vaccine influenza vaccines janssen life-threatening limitation messenger RNA (mRNA) Moderna mRNA vaccines neurological occurred ocular Older Pain pathophysiological mechanism Pfizer-BioNTech pharmacovigilancce pharmacovigilance Population populations provide reaction Reactions reported Reporting Research Result risk SARS-CoV-2 serious adverse reaction sexual organ Suspected System the United State thrombosis union vaccination Vaccine [DOI] 10.3389/fpubh.2021.756633 PMC 바로가기 [Article Type] Public Health
mRNA Covid-19 vaccines in pregnancy: A systematic reviewResearch Article Published on 2022-02-022022-10-28 Journal: PLoS ONE [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] adverse event adverse events Adverse reaction antibody Antibody Response antibody transfer article available data booster clinical Cochrane Library conducted Coronavirus disease 2019 criteria database described develop dose elicit European fatigue fetal first vaccination FIVE headache IgG infection rate injection interval investigated latency Local manual Moderna mRNA mRNA vaccine mRNA vaccines mRNA-based vaccine objective observational study Pain Pfizer–BioNTech Pregnancy pregnant women Prevent registry reported Research responses Result risk factor robust Safe SARS-CoV-2 SARS-COV-2 infection searched Seven suggested systematic review systemic adverse events the WHO union vaccination Vaccine vaccine dose were excluded [DOI] 10.1371/journal.pone.0261350 PMC 바로가기 [Article Type] Research Article
Robust induction of neutralizing antibodies against the SARS-CoV-2 Delta variant after homologous Spikevax or heterologous Vaxzevria-Spikevax vaccination동종 Spikevax 또는 이종 Vaxzevria-Spikevax 백신 접종 후 SARS-CoV-2 Delta 변이체에 대한 중화 항체의 강력한 유도Article Published on 2022-02-012022-09-11 Journal: European Journal of Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] antibodies AstraZeneca delta variant followed by Heterologous heterologous immunization homologous immunization Moderna neutralization tests neutralize Neutralizing antibodies neutralizing antibody regimen SARS-CoV-2 sera the SARS-CoV-2 vaccination Vaccine virus neutralization test were assessed [DOI] 10.1002/eji.202149645 PMC 바로가기 [Article Type] Article